Mechlorethamine HCl is an anti-neoplastic agent, prescribed for Hodgkin's disease, non-Hodgkin's lymphoma along with other medications. The risk or severity of adverse effects can be increased when ...

Learn the correct pronunciation of the Mechlorethamine, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, ...

Lugano, Switzerland, February 18, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to note two recent journal publications on ...

MALVERN, Pa.--(BUSINESS WIRE)--Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted marketing ...

Mechlorethamine, commonly known as nitrogen mustard, is already approved for intravenous use in the treatment of mycosis fungoides. Mycosis fungoides is the most common type of cutaneous T-cell ...

First and only FDA-approved topical formulation of mechlorethamine available for patients with stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma who have received prior skin-directed ...

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a ...

Lugano, Switzerland, March 18, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to note the publication of results from the ...